India norfloxacin market is expected to grow at a steady rate during the forecast period. Norfloxacin is a synthetic broad spectrum antibiotic which is mainly used to treat urinary tract infections by hindering bacterial cell division. The India norfloxacin market is driven by rise in geriatric population. Moreover, high prevalence of urinary tract infections (UTI) in the country is forecasted to positively influence the market growth. Large number of clinical trials by key market players is further expected to boost the growth of India Norfloxacin market through FY2027.

The India norfloxacin market is segmented based on product type, source, form, route of administration, distribution channel, application, end user, company, and region. Based on application, the market can be segmented into urinary tract infections, gynaecological infections, bladder infections, inflammation of the prostate gland, gonorrhoea and others. Among these, urinary tract infections segment is expected to witness high growth in the market over the coming years on account of high prevalence of UTI (including both asymptomatic bacteriuria and symptomatic infection) in pregnant women in the country.

The major players operating in the India norfloxacin market are Alkem Laboratories Ltd., Aristo Pharmaceuticals Ltd., Hetero Healthcare Ltd., Taurus Laboratories Pvt. Ltd., Alembic Ltd., Ranbaxy Laboratories Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., IPCA Laboratories Ltd., Emcure Pharmaceuticals Ltd., and others. Major companies are developing advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments to expand their geographic reach and to increase their customer basis.

Years considered for this report:

Historical Years: FY2017-FY2020

Base Year: FY2021

Estimated Year: FY2022

Forecast Period: FY2023–FY2027

Objective of the Study:

  • To analyze and estimate the market size of India norfloxacin market from FY2017 to FY2020.
  • To estimate and forecast the market size of India norfloxacin market from FY2021 to FY2027 and growth rate until FY2027.
  • To classify and forecast India norfloxacin market based on product type, source, form, route of administration, distribution channel, application, end user, company, and regional distribution.
  • To identify dominant region or segment in the India norfloxacin market.
  • To identify drivers and challenges for India norfloxacin market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India norfloxacin market.
  • To identify and analyze the profile of leading players operating in India norfloxacin market.
  • To identify key sustainable strategies adopted by market players in India norfloxacin market. 


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India norfloxacin market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research. 

Key Target Audience:

  • Norfloxacin manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to Norfloxacin

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India norfloxacin market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Norfloxacin Market, By Product Type:
    • Prescription
    • OTC
  • India Norfloxacin Market, By Source:
    • In-house
    • Contract Manufacturing Organizations
  • India Norfloxacin Market, By Form:
    • Tablet
    • Capsule
    • Eye drops
    • Syrup
    • Ointment
    • Injection
  • India Norfloxacin Market, By Route of Administration:
    • Oral
    • Intravenous
    • Topical
    • Ophthalmic
  • India Norfloxacin Market, By Distribution Channel:
    • Online
    • Offline
  • India Norfloxacin Market, By Application:
    • Urinary tract Infections
    • Gynecological Infections
    • Bladder Infections
    • Inflammation of the Prostate Gland
    • Gonorrhea
    • Others
  • India Norfloxacin Market, By End User:
    • Adult
    • Paediatric
  • India Norfloxacin Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India norfloxacin market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India norfloxacin market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Norfloxacin Market

4.    Executive Summary

5.    Manufacturing Norfloxacin

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Norfloxacin

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Norfloxacin Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Product Type (Prescription v/s OTC)

7.2.2.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.3.     By Form (Tablet, Capsule, Eye drops, Syrup, Ointment and Injection)

7.2.4.     By Route of Administration (Oral, Intravenous, Topical, Ophthalmic)

7.2.5.     By Distribution Channel (Online v/s Offline)

7.2.6.     By Application (Urinary tract Infections, gynecological infections, bladder infections, inflammation of the prostate gland, gonorrhea and Others)

7.2.7.     By End User (Adult v/s Paediatric)

7.2.8.     By Region (North, East, South, West)

7.2.9.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Alkem Laboratories Ltd.

14.1.1.1.      Company Brief

14.1.1.2.      Production Plants & Capacity (If Available)

14.1.1.3.      Financials (If Available)

14.1.1.4.      Captive Consumption Vs Merchant Sale

14.1.1.5.      Current & Future Plans

14.1.2.  Aristo Pharmaceuticals Ltd.

14.1.3.  Hetero Healthcare Ltd.

14.1.4.  Taurus Laboratories Pvt. Ltd.

14.1.5.  Alembic Ltd.

14.1.6.  Ranbaxy Laboratories Ltd.

14.1.7.  Cipla Ltd.

14.1.8.  Dr. Reddy’s Laboratories Ltd.

14.1.9.  IPCA Laboratories Ltd.

14.1.10.                Emcure Pharmaceuticals Ltd.

15.  Strategic Recommendations

 16. About Us & Disclaimer